Cargando…

Communication during counseling sessions about inhaled corticosteroids at the community pharmacy

BACKGROUND: Pharmaceutical care is one of the major tasks of pharmacists, which aims to improve patient outcomes. Counseling patients with asthma or chronic obstructive pulmonary disease about their use of inhaled corticosteroids (ICS) might enhance medication adherence and symptom control. Therefor...

Descripción completa

Detalles Bibliográficos
Autores principales: Driesenaar, Jeanine A, De Smet, Peter AGM, van Hulten, Rolf, Hu, Litje, van Dulmen, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098562/
https://www.ncbi.nlm.nih.gov/pubmed/27843303
http://dx.doi.org/10.2147/PPA.S108006
_version_ 1782465802726801408
author Driesenaar, Jeanine A
De Smet, Peter AGM
van Hulten, Rolf
Hu, Litje
van Dulmen, Sandra
author_facet Driesenaar, Jeanine A
De Smet, Peter AGM
van Hulten, Rolf
Hu, Litje
van Dulmen, Sandra
author_sort Driesenaar, Jeanine A
collection PubMed
description BACKGROUND: Pharmaceutical care is one of the major tasks of pharmacists, which aims to improve patient outcomes. Counseling patients with asthma or chronic obstructive pulmonary disease about their use of inhaled corticosteroids (ICS) might enhance medication adherence and symptom control. Therefore, effective pharmacist–patient communication is very important. In this regard, both affective communication, for handling emotions, and instrumental communication, for exchanging biomedical and lifestyle information, are relevant. Until now, only few studies have explored pharmacist–patient communication, and further insight is needed in this regard. The aim of this study is to investigate how pharmacists and pharmacy technicians communicate about ICS with patients with asthma and/or chronic obstructive pulmonary disease, what topics are discussed by them, and whether pharmacists and pharmacy technicians differ in their communication during counseling sessions. METHODS: Patients aged ≥18 years who had used ICS for at least 1 year and filled at least two ICS prescriptions in the preceding year were recruited through 12 pharmacies. Participants had one counseling session with a pharmacist or a pharmacy technician, which was video-recorded. The process and content of the provider–patient communication were analyzed using the Roter interaction analysis system, adapted to the pharmaceutical setting. RESULTS: A total of 169 sessions were recorded and analyzed. The communication appeared largely instrumental. Lifestyle, psychosocial issues, and ICS adherence were not discussed in detail. The pharmacists had longer conversations and more affective talk than the pharmacy technicians. CONCLUSION: Pharmacists and pharmacy technicians may need to pay more attention to ICS adherence, lifestyle, and psychosocial topics. They differed in their communication; the pharmacists exhibited more affective behavior and discussed medical and therapeutic issues more extensively compared to the pharmacy technicians. Educational courses for pharmacists and pharmacy technicians could focus more on the discussion of adherence, lifestyle, and psychosocial topics with patients.
format Online
Article
Text
id pubmed-5098562
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-50985622016-11-14 Communication during counseling sessions about inhaled corticosteroids at the community pharmacy Driesenaar, Jeanine A De Smet, Peter AGM van Hulten, Rolf Hu, Litje van Dulmen, Sandra Patient Prefer Adherence Original Research BACKGROUND: Pharmaceutical care is one of the major tasks of pharmacists, which aims to improve patient outcomes. Counseling patients with asthma or chronic obstructive pulmonary disease about their use of inhaled corticosteroids (ICS) might enhance medication adherence and symptom control. Therefore, effective pharmacist–patient communication is very important. In this regard, both affective communication, for handling emotions, and instrumental communication, for exchanging biomedical and lifestyle information, are relevant. Until now, only few studies have explored pharmacist–patient communication, and further insight is needed in this regard. The aim of this study is to investigate how pharmacists and pharmacy technicians communicate about ICS with patients with asthma and/or chronic obstructive pulmonary disease, what topics are discussed by them, and whether pharmacists and pharmacy technicians differ in their communication during counseling sessions. METHODS: Patients aged ≥18 years who had used ICS for at least 1 year and filled at least two ICS prescriptions in the preceding year were recruited through 12 pharmacies. Participants had one counseling session with a pharmacist or a pharmacy technician, which was video-recorded. The process and content of the provider–patient communication were analyzed using the Roter interaction analysis system, adapted to the pharmaceutical setting. RESULTS: A total of 169 sessions were recorded and analyzed. The communication appeared largely instrumental. Lifestyle, psychosocial issues, and ICS adherence were not discussed in detail. The pharmacists had longer conversations and more affective talk than the pharmacy technicians. CONCLUSION: Pharmacists and pharmacy technicians may need to pay more attention to ICS adherence, lifestyle, and psychosocial topics. They differed in their communication; the pharmacists exhibited more affective behavior and discussed medical and therapeutic issues more extensively compared to the pharmacy technicians. Educational courses for pharmacists and pharmacy technicians could focus more on the discussion of adherence, lifestyle, and psychosocial topics with patients. Dove Medical Press 2016-11-02 /pmc/articles/PMC5098562/ /pubmed/27843303 http://dx.doi.org/10.2147/PPA.S108006 Text en © 2016 Driesenaar et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Driesenaar, Jeanine A
De Smet, Peter AGM
van Hulten, Rolf
Hu, Litje
van Dulmen, Sandra
Communication during counseling sessions about inhaled corticosteroids at the community pharmacy
title Communication during counseling sessions about inhaled corticosteroids at the community pharmacy
title_full Communication during counseling sessions about inhaled corticosteroids at the community pharmacy
title_fullStr Communication during counseling sessions about inhaled corticosteroids at the community pharmacy
title_full_unstemmed Communication during counseling sessions about inhaled corticosteroids at the community pharmacy
title_short Communication during counseling sessions about inhaled corticosteroids at the community pharmacy
title_sort communication during counseling sessions about inhaled corticosteroids at the community pharmacy
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098562/
https://www.ncbi.nlm.nih.gov/pubmed/27843303
http://dx.doi.org/10.2147/PPA.S108006
work_keys_str_mv AT driesenaarjeaninea communicationduringcounselingsessionsaboutinhaledcorticosteroidsatthecommunitypharmacy
AT desmetpeteragm communicationduringcounselingsessionsaboutinhaledcorticosteroidsatthecommunitypharmacy
AT vanhultenrolf communicationduringcounselingsessionsaboutinhaledcorticosteroidsatthecommunitypharmacy
AT hulitje communicationduringcounselingsessionsaboutinhaledcorticosteroidsatthecommunitypharmacy
AT vandulmensandra communicationduringcounselingsessionsaboutinhaledcorticosteroidsatthecommunitypharmacy